Experienced matrix leader in product development, I support Pharma, Biotech, Medtech, Start-up and Investment Companies in optimizing the strategic and operational management of their asset portfolio to maximize patient access to innovative therapeutic solutions. I provide expertise in defining and executing candidate development strategies along with portfolio, program, project, and alliance management services through tailored […]
Jay Roberts has been a senior strategic executive in the healthcare industry for over 30 years. He is a partner with Ventac Partners, a global catalyst in life sciences creating breakthrough companies bringing remarkable scientific innovation to patients worldwide. He also serves as a Venture Partner for DigiLife Fund II, leading fundraising, due diligence and […]
I am a senior biotech and pharma strategist with over 20 years of experience across medical affairs, clinical development, external innovation, portfolio strategy, and venture-facing due diligence. My background spans oncology, hematology, rare diseases, RNA therapeutics, CNS, dermatology, regenerative medicine, and longevity biology. I have held leadership roles in global and regional organizations, including Celgene, […]
Austin Smith is a GMC-registered physician and pharmaceutical consultant with over 15 years in oncology drug development, dually trained in medical oncology and pharmaceutical medicine. He serves as Chief Medical Officer at Oxcia AB and Head of Clinical Development at Ariceum Therapeutics, leading early-phase and first-in-human programmes across haematological malignancies, radioligand theranostics, and orphan disease. […]
I am a breast medical oncologist, clinical researcher, and academic physician specializing in breast cancer care and clinical trials. As Director of Breast Medical Oncology and Director of the Breast Cancer Clinical Trials Program at MD Anderson Cancer Center at Cooper, I lead efforts to advance innovative treatment strategies and improve outcomes for patients with […]
Mohamed Abozeid, MD PhD, is a Medical Oncologist at The Royal Marsden NHS Foundation Trust, one of the world’s leading cancer centres. He combines clinical practice with academic teaching, serving as a Lecturer and honorary consultant at a faculty of medicine Suez Canal University. He earned his PhD from Padua University following his medical training. […]
Stephen Floor is a subject-matter expert in RNA science and medicine and computational biology with over 15 years of experience spanning academic research and biotechnology. His expertise bridges molecular biology, RNA biology, and computational approaches to understanding gene expression and developing RNA-based therapeutics.nnHe earned his PhD from UCSF in 2011, where he has built deep […]
20+ years in academia (basic and clinical research, education) 20+ years in pharma in development at BMS and NovoNordisk, then member of the Global Therapeutic Area Leadership at PAREXEL, most recently as an independent consultant to small and medium biopharma and pharma, especially working with early development on CDPs and protocol development, from scientific background […]
I am a software and medical device product development leader with nearly two decades of experience in regulated and safety-critical environments. My passion is solving complex problems at the intersection of technology and healthcare, where innovation must meet the highest standards of safety, quality, and compliance. I’ve built and led cross-disciplinary teams of engineers, developers, […]
I’ve spent 30 years in medtech and biotech—from the bench to the production floor to the C-suite—bringing more than 25 products to market across FDA 510(k), CE/MDR, and TGA pathways. I’ve seen exceptional science fail, not because the innovation wasn’t strong, but because the operational, regulatory, and governance foundations weren’t in place to support commercialization. […]